ArticleVirulence2026
Comparative analysis of viral biological characteristics and pathogenicity of representative prevalent avian reovirus strains from genotypes I to V.
Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The variable pathogenicity of avian reovirus (ARV), driven by genotypic diversity, poses significant control challenges to the global poultry industry. However, biological and pathogenic distinctions among genotypes remain poorly characterized. We performed a comprehensive comparison of 14 ARV strains (genotypes I-V), evaluating viral biological characteristics and pathogenicity indicators. Phylogenetic analysis of these isolates and field strains in China based on the σC gene revealed co-circulation of multiple genotypes (predominantly I and II), with epidemic strains actively evolving and genetically distant from the S1133 vaccine. Structural analysis localized conformational B-cell epitopes of σC protein primarily to the C-terminal globular head and neck, with a highly conserved core antigenic scaffold formed by key residues, while peripheral residues showed genotype-specific variation. Recombination analysis suggests that genotype V (SDAU-G5-DG) likely emerged through recombination with genotype VI. Genotypes I (SDAU-G1-AN4) and IV (SDAU-G4-m4) exhibited enhanced replication and lethality in cell culture and chicken embryos. In vivo, all strains caused growth retardation, lameness, tenosynovitis, and immune organ atrophy, but the tested genotypes I and IV were most virulent. Distinct tissue tropisms were observed: genotypes I and V induced cardiac and hepatic lesions, whereas genotypes I and III caused intestinal damage. Immunologically, genotypes I and IV triggered strong early pro-inflammatory cytokine responses and significantly upregulated MMP13 and Wnt14 at 7 dpi. This points to severe immune activation and a high risk of joint injury. These distinct biological and pathogenic profiles among the tested ARV strains underscore the need for genotype-specific vaccine strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.